DNA Capital | DNA VC II
◆ Check Size
◆ Location
Brazil
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Supporting innovative early-stage companies with capital and resources to develop and grow, targeting healthtech and scalable services that expand access and improve quality of care in Brazil
◆ About DNA Capital
DNA Capital is a global healthcare investment firm that partners with exceptional founders and teams across early to late stages to build leading healthcare and healthtech businesses. Operating from offices in São Paulo, Brazil, and San Francisco, USA, the firm focuses on high-quality, ethical, and humane products and services throughout the healthcare sector. They provide capital, experienced partners, operators, and a network of advisors to help portfolio companies thrive.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Luiz Noronha | Partner | partner | |
| Partha Mishra | Partner | partner | |
| Pedro Bueno | Founder | founder |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does DNA VC II invest in?
DNA VC II invests in Healthtech Infrastructure, Digital Health and Medtech at the seed and series-a stages.
Which geographies does DNA VC II focus on?
DNA VC II focuses on Brazil, and is headquartered in Brazil.
What is DNA VC II's typical check size?
DNA VC II typically writes checks of $0.5M to $50M.